Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient
US9301954B2 · kind B2 · utility
1Cited by
1References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 4, 2011 |
| Grant date | Apr 5, 2016 |
| Priority date | — |
| Expiry date | Mar 4, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for preventing or treating osteoarthritis comprising administrating rebamipide or a pharmaceutical composition comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier to a subject in need thereof. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.